Cargando...
Pharmacotherapy for Non-alcoholic Fatty Liver Disease
Life style modifications and optimization of the management of cardio-metabolic comorbidities are currently the mainstay of treatment for patients with non-alcoholic fatty liver disease (NAFLD). Pharmacotherapy to halt or reverse hepatic histological injury and prevent the development of end stage l...
Guardado en:
| Publicado en: | Semin Liver Dis |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5401764/ https://ncbi.nlm.nih.gov/pubmed/26378648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0035-1562951 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|